PTHS (PTHS) reported R&D of $186K in Q1 2026.

How has PTHS's R&D changed year-over-year?

PTHS's R&D decreased by 4.1% year-over-year, from $194K to $186K.

What is the long-term trend for PTHS's R&D?

Over 3 years (2022 to 2025), PTHS's R&D has grown at a 46.3% compound annual growth rate (CAGR), from $391.73K to $1.23M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

PTHS PTHS R&D

R&D at other companies

Cumberland PharmaceuticalsCPIX

$1.46M+12.6%

Scilex Holding CompanySCLX

$3.21M+30.7%

Journey Medical CorporationDERM

$154K-29.4%

Opko HealthOPK

$29.2M-5.3%

Zevra Therapeutics, Inc.ZVRA

$4.39M+34.8%

Theravance BiopharmaTBPH

$5.83M-49.1%

Other financials

Income statement

See full

Revenue$10.9M—

Gross profit$9.2M—

Operating income-$13.1M-614%

Net income-$10.2M-420%

EPS (diluted)-$3.09+3.7%

Balance sheet

See full

Cash & equivalents$32.0M+24,250%

Total debt$29.6M—

Total equity$35.1M+937%

Total assets$145.4M+15,855%

Cash flow

See full

Operating cash flow-$13.1M-1,977%

CapEx$194.0K—

Free cash flow-$13.3M-2,008%

Valuation

See full

Market cap$98.22M+92.4%

Enterprise value$95.89M—

P/S3.6×—

Profitability

See full

Gross margin79.6%—

Operating margin-157.7%—

Net margin-186.2%—

FCF margin-60.8%—

Returns & leverage

See full

Return on equity-333.8%—

Debt / equity0.8×—

Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTHS's R&D?: PTHS (PTHS) reported R&D of $186K in Q1 2026.
How has PTHS's R&D changed year-over-year?: PTHS's R&D decreased by 4.1% year-over-year, from $194K to $186K.
What is the long-term trend for PTHS's R&D?: Over 3 years (2022 to 2025), PTHS's R&D has grown at a 46.3% compound annual growth rate (CAGR), from $391.73K to $1.23M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.